D
Deborah Grady
Researcher at University of California, San Francisco
Publications - 276
Citations - 44747
Deborah Grady is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Estrogen & Hormone therapy. The author has an hindex of 88, co-authored 269 publications receiving 43348 citations. Previous affiliations of Deborah Grady include Veterans Health Administration & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Efficacy of screening mammography. A meta-analysis.
Karla Kerlikowske,Deborah Grady,Deborah Grady,Susan M. Rubin,Christian Sandrock,Virginia L. Ernster +5 more
TL;DR: Screening mammography may be effective in reducing breast cancer mortality in women aged 40 to 49 years after 10 to 12 years of follow-up, but the same benefit could probably be achieved by beginning screening at menopause or 50 years of age.
Journal ArticleDOI
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Lori Mosca,Lawrence J. Appel,Emelia J. Benjamin,Kathy Berra,Nisha Chandra-Strobos,Rosalind P. Fabunmi,Deborah Grady,Constance K. Haan,Sharonne N. Hayes,Debra R. Judelson,Nora L. Keenan,Patrick McBride,Suzanne Oparil,Pamela Ouyang,Mehmet C. Oz,Michael E. Mendelsohn,Richard C. Pasternak,Vivian W. Pinn,Rose Marie Robertson,Karin Schenck-Gustafsson,Cathy A. Sila,Sidney C. Smith,George Sopko,Anne L. Taylor,Brian W. Walsh,Nanette K. Wenger,Christine L. Williams +26 more
TL;DR: In the wake of the reports of the Women’s Health Initiative and the Heart and Estrogen/Progestin Replacement Study, which unexpectedly showed that combination hormone therapy was associated with adverse CVD effects, there is a heightened need to critically review and document strategies to prevent CVD in women.
Journal ArticleDOI
Hormone therapy to prevent disease and prolong life in postmenopausal women
Deborah Grady,Susan M. Rubin,Diana B. Petitti,Cary Fox,Dennis M. Black,Bruce Ettinger,Virginia L. Ernster,Steven R. Cummings +7 more
TL;DR: There is evidence that estrogen therapy decreases risk for coronary heart disease and for hip fracture, but long-term estrogen therapy increases risk for endometrial cancer and may be associated with a small increase in risk for breast cancer.
Journal ArticleDOI
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
Deborah Grady,Tebeb Gebretsadik,Tebeb Gebretsadik,Tebeb Gebretsadik,Karla Kerlikowske,Karla Kerlikowske,Karla Kerlikowske,Virginia L. Ernster,Virginia L. Ernster,Virginia L. Ernster,Diana B. Petitti,Diana B. Petitti,Diana B. Petitti +12 more
TL;DR: Endometrial cancer risk increases substantially with long duration of unopposed estrogen use, and this increased risk persists for several years after discontinuation of estrogen therapy, similar to the increased risk of developing the disease.
Journal ArticleDOI
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
TL;DR: There are plausible biological mechanisms by which estrogen might lead to improved cognition, reduced risk for dementia, or improvement in the severity of dementia, but large placebo-controlled trials are required to address estrogen's role in prevention and treatment of Alzheimer disease and other dementias.